Biosimilars vs. originators: A comprehensive guide for nurses on efficacy, safety, and patient care.

Q3 Nursing

Nursing Pub Date : 2024-12-01 Epub Date: 2024-11-15 DOI:10.1097/NSG.0000000000000105

Elizabeth Hughes, Sharon Tymkiw, Karen M Vuckovic

引用次数: 0

Abstract

Abstract: Biosimilars can potentially increase patient treatment options, allowing access to expensive biologic medications. As frontline caregivers, nurses are uniquely positioned to educate patients on their safety and effectiveness. This article discusses biosimilars and standard terms, their development process, and strategies for nurses to provide effective patient education about these medications.

查看原文本刊更多论文

生物仿制药与原药：护士对疗效、安全性和患者护理的综合指南。

摘要：生物仿制药可以潜在地增加患者的治疗选择，使他们能够获得昂贵的生物药物。作为一线护理人员，护士在教育患者安全性和有效性方面具有独特的地位。本文讨论了生物类似药和标准术语，它们的发展过程，以及护士提供有效的患者药物教育的策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nursing Medicine-Medicine (all)

CiteScore

0.80

自引率

0.00%

发文量

338

期刊介绍： Nursing2020 (ISSN 0360-4039; online ISSN 1538-8689) published its first issue in November 1971, under founders Gene W. Jackson and Daniel Cheney. In the intervening years, its circulation has grown to over 150,000, making it one of the largest nursing journals in the world. Published monthly, Nursing2020 is widely regarded as offering current, practical contents to its readers, and has won many editorial awards testifying to the quality of its copy and graphics. The editorial and clinical staff, a 19-member Editorial Board of distinguished clinicians and practitioners, and over 100 invited reviewers help ensure the quality of this publication.